Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

NewLink Genetics Corp (NASDAQ:NLNK)

18.59
Delayed Data
As of Apr 24
 +0.51 / +2.82%
Today’s Change
9.23
Today|||52-Week Range
25.17
+80.84%
Year-to-Date
Six Stocks Spiking Up With Huge Volume
Apr 19 / TheStreet.com - Paid Partner Content
 

Today’s Trading

Previous close18.08
Today’s open18.16
Day’s range18.11 - 19.42
Volume795,692
Average volume (3 months)499,985
Market cap$528.3M
Dividend yield--
Data as of 3:59pm ET, 04/24/2017

Growth & Valuation

Earnings growth (last year)-108.51%
Earnings growth (this year)+4.76%
Earnings growth (next 5 years)--
Revenue growth (last year)-47.78%
P/E ratioNM
Price/Sales8.33
Price/Book4.07

Competitors

 Today’s
change
Today’s
% change
CARACara Therapeutics In...+0.08+0.48%
CRHMCRH Medical Corp-0.55-7.48%
ITCIIntra-Cellular Thera...+0.05+0.40%
PGNXProgenics Pharmaceut...-0.05-0.65%
Data as of 4:02pm ET, 04/24/2017

Financials

Next reporting dateMay 4, 2017
EPS forecast (this quarter)-$0.82
Annual revenue (last year)$35.8M
Annual profit (last year)-$85.2M
Net profit margin-238.08%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, Chief Executive &
Scientific Officer
Charles J. Link
President, Director &
Chief Medical Officer
Nicholas N. Vahanian
Corporate headquarters
Ames, Iowa

Forecasts


Search for Jobs